Organigram agrees to acquire Aurora Cannabis as Curaleaf launches hostile bid
Organigram plans to buy Aurora Cannabis as Curaleaf pursues a hostile bid, according to Seeking Alpha. Deal terms are not detailed in the report.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Organigram plans to buy Aurora Cannabis, while Curaleaf has put forward a hostile bid for the same company, according to Seeking Alpha.
The report does not disclose the price or other terms of either offer. The competing approaches leave the outcome of the situation open.
why it matters
A hostile bid usually raises uncertainty for the shares of both companies and can affect the final value of a deal. The next steps taken by the companies will determine which terms are accepted.
market impact
Aurora Cannabis and Organigram shares: competing offers add uncertainty over the deal outcome.
tags
instruments
sources
- Organigram to buy Aurora Cannabis amid hostile bid from Curaleaf — Seeking Alpha, 3 November 2026 at 15:02 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗